FAKTOR-OPTIONSSCHEIN - AMGEN | Delayed Deutsche Boerse AG 14:31:30 2024-06-07 EDT | ||
| 0.58 EUR | -3.33% |
|
| Current month | +3.45% | ||
| 1 month | +3.45% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 0.58 | -3.33% |
| 24-06-06 | 0.6 | -4.76% |
| 24-06-05 | 0.63 | 0.00% |
| 24-06-04 | 0.63 | +1.61% |
| 24-06-03 | 0.62 | +6.90% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 02:31 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SQ6CH2 |
| ISIN | DE000SQ6CH22 |
| Date issued | 2022-12-14 |
| Strike | 276.6 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.18 € |
|---|---|
| Lowest since issue | 0.19 € |
| Spread | 0.02 € |
| Spread % | 3.33% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.7
USD
Average target price
316.3
USD
Spread / Average Target
+3.46%
- Stock Market
- Certificates
- Certificat
